BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 13, 2006
View Archived Issues
Snapshots of histone deacetylases (HDACs) as novel effective targets in cancer therapy: Part I
Read More
Galenea to focus on development of drugs to treat CNS diseases
Read More
DOR advances mucosal vaccine for botulinum toxin
Read More
PPARgamma agonists in cancer highlighted at AACR
Read More
Dosing completed in phase I study of Sinovac's H5N1 vaccine
Read More
Promising results seen with denosumab in postmenopausal osteoporosis
Read More
STRIDE studies reveal effects of sitaxsentan in pulmonary arterial hypertension
Read More
MPC-7869 beneficial in patients with mild, but not moderate, Alzheimer's disease
Read More
MBP-8298 delays multiple sclerosis progression
Read More
XP-13512 significantly improves restless legs syndrome
Read More
Garenoxacin effective in community-acquired pneumonia caused by resistant strains
Read More
Enrollment ahead of schedule in phase III study of VP-4896 for Alzheimer's
Read More
ProMetic begins enrollment in phase Ib/II study of PBI-1402
Read More
AlphaRx grants Proprius rights to Indaflex
Read More
Emisphere expands enrollment in phase II oral insulin trial
Read More
Phase II study of Aridol for COPD completes enrollment
Read More
Myriad Genetics and Abbott establish broad drug discovery collaboration
Read More
Schering-Plough selects compound from Pharmacopeia collaboration
Read More
Tostrex completes European MRP
Read More
Expansion of Biolex's collaboration with Medarex
Read More
Affymax studies Hematide in pure red cell aplasia patients
Read More
Amigal recommended for European orphan drug status for Fabry's disease
Read More
Preclinical update on ARRY-142886
Read More
Small-molecule pan-ErbB inhibitor selected by J&J as development candidate
Read More
Novel analgesic agents reported in recent patents
Read More
New AIDS diagnostic developed by Bio-Rad Pasteur
Read More
Recent patents describe novel agents for neurological disorders
Read More
mTOR inhibitor from Biotica shows potential for glioblastoma multiforme
Read More